Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Psychotropic Medication Use in Parents of Children Diagnosed With Cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Don't Rush It: Conservative Care in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Epidemiology and Risk Factors of Infection in Early Childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Probiotics and Child Care Absence Due to Infections: A Randomized Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cesarean Delivery and Body Mass Index at 6 Months and Into Childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Objective measures on parental distress after a child's cancer diagnosis are sparse. We examined the risk for first prescription of psychotropic medicine among parents of children with cancer compared with parents of children who were cancer free. In addition, we examined if sociodemographic and clinical characteristics are associated with risk of first prescription of psychotropic medication in parents of children with cancer.

METHODS: We followed all parents of children with cancer (N = 6744) from the Danish Cancer Registry (1998-2014) using parents of matched children who were cancer free (N = 65 747) as a comparison. To identify vulnerable subgroups among parents of children with cancer, we followed all parents of children with cancer from the Childhood Cancer Registry (2003-2015; N = 3290 parents). In Cox proportional hazard models, we estimated hazard ratios (HRs) for a first prescription of psychotropic medication according to cancer status of the child and sociodemographic and clinical risk factors.

RESULTS: Parents of children with cancer were at increased risk for a first prescription of psychotropic medication compared with parents of children who were cancer free up to 2 years after the diagnosis, the risk being highest in the first year (HR, 1.83 [95% confidence interval (CI), 1.66-2.01]). Parents of children with cancer, especially parents who lost their child, had an increased risk for a first prescription of hypnotics (HR, 6.91; 95% CI, 3.50-13.66) and anxiolytics (HR, 4.55, 95% CI, 1.57-13.17) in the first year after diagnosis.

CONCLUSIONS: Efforts should be made to ensure that medical teams are adequately educated to address stress responses in the parents.

OriginalsprogEngelsk
TidsskriftPediatrics
Vol/bind143
Udgave nummer5
ISSN0031-4005
DOI
StatusUdgivet - maj 2019

Bibliografisk note

Copyright © 2019 by the American Academy of Pediatrics.

ID: 57382782